Clinical Trial Update: Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses [NA]

View source ↗

Summary

This clinical trial investigates voice-based biomarkers as a novel approach to monitor and predict relapses in schizophrenia. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: Schizophrenia | NA | Status: RECRUITING